Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Dual Actions of Ketorolac in Metastatic Ovarian Cancer.

Hudson LG, Cook LS, Grimes MM, Muller CY, Adams SF, Wandinger-Ness A.

Cancers (Basel). 2019 Jul 24;11(8). pii: E1049. doi: 10.3390/cancers11081049. Review.

2.

Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.

Flies DB, Higuchi T, Harris JC, Jha V, Gimotty PA, Adams SF.

Oncoimmunology. 2016 May 13;5(8):e1185583. doi: 10.1080/2162402X.2016.1185583. eCollection 2016 Aug.

3.

Oxygen rotational temperature determination using empirical analyses of C(3)Π(v' = 2) ← X(3)Σ(v'' = 0) transitions.

Adams SF, Wu Y, Zhang Z.

Appl Spectrosc. 2015 Sep;69(9):1036-41. doi: 10.1366/14-07772.

PMID:
26414523
4.

CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer.

Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams SF.

Cancer Immunol Res. 2015 Nov;3(11):1257-68. doi: 10.1158/2326-6066.CIR-15-0044. Epub 2015 Jul 2.

5.

A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.

Guo Y, Kenney SR, Cook L, Adams SF, Rutledge T, Romero E, Oprea TI, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG.

Clin Cancer Res. 2015 Nov 15;21(22):5064-72. doi: 10.1158/1078-0432.CCR-15-0461. Epub 2015 Jun 12.

6.

Immunotherapy for ovarian cancer: what are the targets of the future?

Adams SF, Benencia F.

Future Oncol. 2015;11(9):1293-6. doi: 10.2217/fon.15.44. No abstract available.

7.

Reduction of breakdown threshold by metal nanoparticle seeding in a DC microdischarge.

Sawyer J, Abboud J, Zhang Z, Adams SF.

Nanoscale Res Lett. 2015 Jan 28;10:15. doi: 10.1186/s11671-014-0709-y. eCollection 2015.

8.

Spectroscopic study of N2(b1Πu, ν = 8) by atmospheric-pressure resonant-enhanced multiphoton ionization and fluorescence detection.

Adams SF, Williamson JM.

J Phys Chem A. 2013 Dec 19;117(50):13535-42. doi: 10.1021/jp407412t. Epub 2013 Oct 4.

PMID:
24047155
9.

Control of current and voltage oscillations in a short dc discharge making use of external auxiliary electrode.

Mustafaev AS, Demidov VI, Kaganovich I, Adams SF, Koepke ME, Grabovskiy A.

Rev Sci Instrum. 2012 Oct;83(10):103502. doi: 10.1063/1.4757111.

PMID:
23126761
10.

Flame temperature measurements by radar resonance-enhanced multiphoton ionization of molecular oxygen.

Wu Y, Sawyer J, Zhang Z, Adams SF.

Appl Opt. 2012 Oct 1;51(28):6864-9. doi: 10.1364/AO.51.006864.

PMID:
23033104
11.

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G.

Gynecol Oncol. 2012 Feb;124(2):192-8. doi: 10.1016/j.ygyno.2011.09.039. Epub 2011 Oct 29.

12.

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer.

Adams SF, Marsh EB, Elmasri W, Halberstadt S, Vandecker S, Sammel MD, Bradbury AR, Daly M, Karlan B, Rubin SC.

Gynecol Oncol. 2011 Dec;123(3):486-91. doi: 10.1016/j.ygyno.2011.08.032. Epub 2011 Sep 25.

13.

Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.

Hagemann AR, Cadungog M, Hagemann IS, Hammond R, Adams SF, Chu CS, Rubin SC, Zhang L, Addya K, Birrer MJ, Gimotty PA, Coukos G.

Cancer Biol Ther. 2011 Aug 15;12(4):357-66. Epub 2011 Aug 15.

14.

Vaginal cuff dehiscence after robotic total laparoscopic hysterectomy.

Robinson BL, Liao JB, Adams SF, Randall TC.

Obstet Gynecol. 2009 Aug;114(2 Pt 1):369-71. doi: 10.1097/AOG.0b013e3181af68c6.

15.

Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.

Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G.

Cancer. 2009 Jul 1;115(13):2891-902. doi: 10.1002/cncr.24317.

16.

Formation and electron-ion recombination of N4(+) following photoionization in near-atmospheric pressure N2.

Adams SF, DeJoseph CA Jr, Williamson JM.

J Chem Phys. 2009 Apr 14;130(14):144316. doi: 10.1063/1.3097757.

PMID:
19368454
17.

PDGFR-alpha as a potential therapeutic target in uterine sarcomas.

Adams SF, Hickson JA, Hutto JY, Montag AG, Lengyel E, Yamada SD.

Gynecol Oncol. 2007 Mar;104(3):524-8. Epub 2006 Oct 17.

PMID:
17049587
18.

Refusal of treatment during pregnancy.

Adams SF, Mahowald MB, Gallagher J.

Clin Perinatol. 2003 Mar;30(1):127-40, vii-viii.

PMID:
12696791
19.

An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium.

Adams SF, Yamada SD, Montag A, Rotmensch JR.

Gynecol Oncol. 2001 Nov;83(2):418-21.

PMID:
11606109
20.

Benzodiazepine tranquilizers and the risk of accidental injury.

Oster G, Huse DM, Adams SF, Imbimbo J, Russell MW.

Am J Public Health. 1990 Dec;80(12):1467-70.

21.

Accident- and injury-related health-care utilization among benzodiazepine users and nonusers.

Oster G, Russell MW, Huse DM, Adams SF, Imbimbo J.

J Clin Psychiatry. 1987 Dec;48 Suppl:17-21. Review.

PMID:
2891685
22.

RESPONSE OF PREGNANT HUMAN UTERUS TO OXYTOCIN GIVEN INTRANASALLY.

TALLEDO E, ADAMS SF, ZUSPAN FP.

JAMA. 1964 Aug 3;189:348-50. No abstract available.

PMID:
14160506
23.

Use of vegetables in infant feeding through the ages.

ADAMS SF.

J Am Diet Assoc. 1959 Jul;35(7):692-703. No abstract available.

PMID:
13664460

Supplemental Content

Loading ...
Support Center